Latanoprost and Anterior chamber disorder - a phase IV clinical study of FDA data

Summary:

Anterior chamber disorder is found among people who take Latanoprost, especially for people who are male, 20-29 old.

The phase IV clinical study analyzes which people take Latanoprost and have Anterior chamber disorder. It is created by eHealthMe based on reports of 25,371 people who have side effects when taking Latanoprost from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jul, 28, 2022

25,371 people reported to have side effects when taking Latanoprost.
Among them, 18 people (0.07%) have Anterior chamber disorder.


What is Latanoprost?

Latanoprost has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 25,669 Latanoprost users for its effectiveness, alternative drugs and more.

What is Anterior chamber disorder?

Anterior chamber disorder is found to be associated with 125 drugs and 66 conditions by eHealthMe.

Number of Latanoprost and Anterior chamber disorder reports submitted per year:

Could Latanoprost cause Anterior chamber disorder?

Gender of people who have Anterior chamber disorder when taking Latanoprost *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Anterior chamber disorder when taking Latanoprost *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 92.86 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 7.14 %

Common drugs people take besides Latanoprost *:

  1. Timolol Maleate: 13 people, 72.22%
  2. Atropine: 11 people, 61.11%
  3. Acetazolamide: 7 people, 38.89%
  4. Dorzolamide Hydrochloride: 6 people, 33.33%
  5. Trusopt: 4 people, 22.22%
  6. Timoptic: 2 people, 11.11%
  7. Timolol: 1 person, 5.56%
  8. Pilocarpine Hydrochloride: 1 person, 5.56%
  9. Methylprednisolone: 1 person, 5.56%
  10. Methotrexate: 1 person, 5.56%

Common side effects people have besides Anterior chamber disorder *:

  1. Intraocular Pressure Increased: 18 people, 100.00%
  2. Drug Ineffective: 18 people, 100.00%
  3. Visual Acuity Tests Abnormal: 9 people, 50.00%
  4. Iridocyclitis (inflammation of the iris and ciliary body of the eye): 5 people, 27.78%
  5. Hyphaema (collection of blood inside the front part of the eye): 5 people, 27.78%
  6. Visual Field Defect: 2 people, 11.11%
  7. Visual Acuity Reduced (reduced clearness of vision): 2 people, 11.11%
  8. Loose Tooth: 1 person, 5.56%
  9. Gastrointestinal Carcinoma (cancer of stomach or intestine): 1 person, 5.56%
  10. Flat Anterior Chamber Of Eye: 1 person, 5.56%

Common conditions people have *:

  1. Intraocular Pressure Increased: 17 people, 94.44%
  2. Osteoporosis (bones weak and more likely to break): 1 person, 5.56%
  3. Eye Inflammation: 1 person, 5.56%
  4. Eye Disorder: 1 person, 5.56%
  5. Cycloplegia (paralysis of the ciliary muscle of the eye): 1 person, 5.56%
  6. Central Nervous System Lymphoma (cancer of central nervous system forms in lymph tissue): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Latanoprost and have Anterior chamber disorder?

Check whether Anterior chamber disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Latanoprost:

Anterior chamber disorder treatments and more:

COVID vaccines that are related to Anterior chamber disorder:

How severe was Anterior chamber disorder and when was it recovered:

Expand to all the drugs that have ingredients of latanoprost:

All the drugs that are associated with Anterior chamber disorder:

All the conditions that are associated with Anterior chamber disorder:

How the study uses the data?

The study uses data from the FDA. It is based on latanoprost (the active ingredients of Latanoprost) and Latanoprost (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: